Burlas, Regis

Burlas, Regis was paid $1.33M by Medicaid between Jan 2018 and Jun 2024, across 41 billing codes. Its largest line is G0483, Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed — 46% of everything it billed.

Compared with peers

Next to other Anesthesiology Physician providers in Ohio

Rank by total paid#4 of 79

Median peer was paid$29K

This provider vs. median47×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,546	$85K
2019	2,687	$118K
2020	3,301	$190K
2021	4,487	$293K
2022	7,817	$570K
2023	903	$51K
2024incomplete	866	$27K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
G0483	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed	46%	5,444	3,849	$608K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	34%	7,719	5,677	$460K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	12%	5,692	4,014	$156K
99204	Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity	2.0%	312	306	$27K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	1.8%	341	330	$24K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	1.1%	327	267	$15K
87481		<1%	19	18	$4K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	39	36	$3K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	39	36	$3K
99215	Doctor's office visit, returning patient (complex)Prolong outpt/office vis	<1%	37	19	$3K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	82	66	$3K
90792	Psychiatric diagnostic evaluation with medical services	<1%	23	22	$3K

29 more codes

87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	19	$3K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	163	$2K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	45	$2K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	218	$2K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	48	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	27	$2K
84439		<1%	53	$1K
86706		<1%	31	$1K
93000		<1%	67	$1K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	19	$1K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	54	$1K
92557		<1%	28	$1K
86780		<1%	35	$873.25
87086	Culture, bacterial; quantitative colony count, urine	<1%	64	$845.56
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	13	$756.84
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	<1%	62	$747.22
83036	Hemoglobin; glycosylated (A1C)	<1%	39	$671.63
86803		<1%	17	$529.38
96127		<1%	194	$489.50
86704		<1%	17	$457.91
36415	Collection of venous blood by venipuncture	<1%	28	$418.58
87340		<1%	17	$392.49
80061	Lipid panel	<1%	12	$391.50
82607		<1%	12	$370.14
71046	Radiologic examination, chest; 2 views	<1%	13	$259.09
82044		<1%	72	$255.96
81002		<1%	89	$207.04
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	12	$103.16
81003		<1%	65	$71.54

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.